Agilent Technologies, Inc. (BVMF:A1GI34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 227.86B +19.5% |
| Revenue (ttm) | 37.49B +8.6% |
| Net Income | 7.32B +18.0% |
| EPS | 25.79 +18.4% |
| Shares Out | n/a |
| PE Ratio | 31.12 |
| Forward PE | 23.76 |
| Dividend | 0.34 (0.45%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 1 |
| Open | 75.76 |
| Previous Close | n/a |
| Day's Range | 75.76 - 75.76 |
| 52-Week Range | 54.83 - 82.14 |
| Beta | 1.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]
Financial Performance
In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial numbers in USD Financial StatementsNews
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of...
Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on October 6...
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. Al...
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Se...
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, follo...
Agilent Introduces the Cary 635 FTIR Spectrometer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fo...
Agilent raises annual profit forecast on improving lab tools demand
Agilent Technologies raised its annual profit forecast on Wednesday, betting on improving demand for its medical tools and equipment used in lab research and drug development.
Agilent Technologies Earnings Call Transcript: Q3 2026
Q3 delivered strong revenue and EPS growth, exceeding guidance, with robust performance in pharma, advanced therapeutics, and China. FY26 guidance was raised for revenue and EPS, supported by innovation, operational execution, and strong end-market trends.
Agilent Technologies Earnings release: Q3 2026
Agilent Technologies released its Q3 2026 earnings on August 26, 2026, summarizing the period's financial results.
Agilent Technologies Slides: Q3 2026
Agilent Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on August 26, 2026.
Agilent Technologies Quarterly report: Q3 2026
Agilent Technologies has published its Q3 2026 quarterly earnings report on August 26, 2026.
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up...
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on beha...
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. ...
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagn...
Agilent Increases Its Investment in HALO X-ray Technologies
NOTTINGHAM, England--(BUSINESS WIRE)-- #AgilentTechnologies--Multimillion dollar investment round to enable HALO to complete regulatory approval of its advanced security screening technology.
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as ...
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chroma...
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free ...
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partn...
Agilent Completes Acquisition of Biocare Medical
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clini...
UMH PROPERTIES, INC. WELCOMES THE 21ST CENTURY ROAD TO HOUSING ACT: A MAJOR BOOST FOR AFFORDABLE MANUFACTURED HOUSING
Freehold, NJ, June 24, 2026 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, today expressed stron...
Tradeweb Announces Date for Second Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, will release financial results for the second quarter of 2026 on Thursday, Ju...
Agilent Technologies Transcript: Jefferies Global Healthcare Conference 2026
Strong revenue and margin growth were driven by innovation, tech refresh cycles, and robust performance in diagnostics, semiconductors, and advanced materials. AI and digital initiatives, new product launches, and strategic M&A are expected to sustain momentum, with significant growth anticipated in China and ATD by 2027.
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate th...